Novo Holdings A/S - Q2 2023 holdings

Add to watchlist

$1.29 Billion is the total value of Novo Holdings A/S's 41 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was 0.0% .

All
New
Buy
Sell
Exit
Unchanged
 Value Shares↓ Weighting
 LANZATECH GLOBAL INC$108,015,391
+76.0%
15,814,8450.0%8.35%
+106.1%
CORT  CORCEPT THERAPEUTICS INC$75,155,338
+2.7%
3,377,7680.0%5.81%
+20.3%
TSM  TAIWAN SEMICONDUCTOR MFG LTDsponsored ads$71,731,918
+8.5%
710,7800.0%5.54%
+27.1%
CABO  CABLE ONE INC$61,833,199
-6.4%
94,1030.0%4.78%
+9.6%
EWTX  EDGEWISE THERAPEUTICS INC$47,055,698
+16.2%
6,071,7030.0%3.64%
+36.1%
MIRM  MIRUM PHARMACEUTICALS INC$43,570,073
+7.7%
1,684,1930.0%3.37%
+26.2%
BABA  ALIBABA GROUP HLDG LTDsponsored ads$41,743,930
-18.4%
500,8270.0%3.23%
-4.4%
BPMC  BLUEPRINT MEDICINES CORP$28,364,413
+40.5%
448,8040.0%2.19%
+64.6%
INSM  INSMED INC$28,259,314
+23.8%
1,339,3040.0%2.18%
+44.9%
FOLD  AMICUS THERAPEUTICS INC$26,324,504
+13.3%
2,095,9000.0%2.03%
+32.6%
ALNY  ALNYLAM PHARMACEUTICALS INC$22,485,667
-5.2%
118,3830.0%1.74%
+11.0%
PHVS  PHARVARIS N V$20,125,981
+87.8%
1,329,3250.0%1.56%
+119.9%
CRNX  CRINETICS PHARMACEUTICALS IN$19,822,000
+12.2%
1,100,0000.0%1.53%
+31.4%
RCKT  ROCKET PHARMACEUTICALS INC$18,280,400
+16.0%
920,0000.0%1.41%
+35.9%
SPRB  SPRUCE BIOSCIENCES INC$14,453,022
-2.7%
6,722,3360.0%1.12%
+14.0%
ABCL  ABCELLERA BIOLOGICS INC$7,279,871
-14.3%
1,126,9150.0%0.56%
+0.4%
 IO BIOTECH INC$6,408,357
+4.3%
3,277,9320.0%0.50%
+21.9%
GLTO  GALECTO INC$6,294,433
+26.6%
2,497,7910.0%0.49%
+48.2%
KNTE  KINNATE BIOPHARMA INC$2,471,592
-51.5%
815,7070.0%0.19%
-43.2%
MQ  MARQETA INC$2,150,387
+6.6%
441,5580.0%0.17%
+24.8%
SPRO  SPERO THERAPEUTICS INC$679,9080.0%468,9020.0%0.05%
+17.8%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-08-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
VANGUARD INDEX FDS41Q3 202264.7%
INOGEN INC34Q2 202268.8%
VANGUARD INTL EQUITY INDEX F29Q4 201637.6%
AMICUS THERAPEUTICS INC22Q3 20234.1%
AKEBIA THERAPEUTICS INC21Q3 20204.8%
VERONA PHARMA PLC21Q2 20221.9%
CORVUS PHARMACEUTICALS INC20Q4 20207.1%
INSPIRE MED SYS INC20Q3 20231.8%
CABLE ONE INC19Q3 20239.7%
FLEXION THERAPEUTICS INC19Q3 20214.7%

View Novo Holdings A/S's complete holdings history.

Latest significant ownerships (13-D/G)
Novo Holdings A/S Q2 2023 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Cyteir Therapeutics, Inc.August 03, 20231,547,1364.4%
Disc Medicine, Inc.June 28, 20231,090,7724.8%
Galera Therapeutics, Inc.June 28, 20232,100,0004.9%
VectivBio Holding AGSold outMay 26, 202300.0%
LanzaTech Global, Inc.February 17, 202315,814,8458.1%
Bolt Biotherapeutics, Inc.Sold outJanuary 04, 202300.0%
Arcellx, Inc.December 12, 20221,750,0004.0%
MINERVA SURGICAL INCNovember 03, 20221,322,4734.5%
Milestone Pharmaceuticals Inc.October 24, 20221,378,5384.6%
Galecto, Inc.September 30, 20222,497,7919.8%

View Novo Holdings A/S's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-05-15
42024-05-14
SC 13G/A2024-05-14
1442024-05-10
SC 13D/A2024-03-28
42024-03-25
SC 13D/A2024-03-25
42024-03-20
SC 13D/A2024-03-20
1442024-03-18

View Novo Holdings A/S's complete filings history.

All filings

View complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (1294170939.0 != 1294170937.0)

Export Novo Holdings A/S's holdings

CSVXLS